5 nov 2019
CPhI Worldwide 2019
Syngene International Ltd.

Syngene International Ltd.

Exhibitor at CPhI Worldwide 2019 stand 121C63, CRO & Clinical Trials Zone

About us

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), is an innovation focused global discovery, development and manufacturing organisation providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’s clientele include world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of its 4000-strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, speed time to market and lower the cost of innovation. For more details, visit www.syngeneintl.com.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America
Affiliated categories: API Contract Manufacturing |Biopharmaceuticals (general category) |Clinical Research (Field) More

Products featured at CPhI Worldwide 2019

Syngene International Ltd.

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 121C63